SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma
August 2019 — SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.
Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.
Our role in the transaction
Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.
Talk to the deal team
Related deals
Capvis has sold hessnatur to Wourth Group
Hess Natur-Textilien GmbH & Co. KG has become part of the international Wourth Group. With the change of ownership from Capvis to Wourth Group, hessnatur is entering its next phase of development. The transaction reflects the company’s successful strategic and business development in recent years, and creates a strong foundation for the future.
Learn moreNiceboy has been acquired by Anacot Capital
Niceboy has been acquired by Anacot Capital, marking the next stage in the company’s development.
Learn moreGens Aurea has completed an IPO on Euronext Milan
Gens Aurea S.p.A. has completed an initial public offering (IPO) on Euronext Milan, raising a total of US$127 million and marking the first IPO on the market since 2024.
Learn more